WAYNE STATE UNIVERSITY

Ferris State partners with Bedrock and BAMF Health to develop a 14-acre tech, entrepreneurship, and life sciences district in Detroit, aiming to foster innovation, create jobs, and enhance the city's knowledge economy.

Wayne State University enrolled Michigan's first patient in a Phase I/II trial testing stem cell-derived gabanergic interneurons to reduce epileptic seizures. The six-hour procedure uses robotic and stereotactic techniques, depositing cells secreting GABA in the hippocampus. The trial aims to assess safety and seizure frequency reduction, with 40 patients to be followed for 15 years post-transplant.

Bedrock plans to build a 220,000-sq-ft Life Science Innovation Building in Detroit, part of a 14-acre innovation district focusing on life sciences, technology, and entrepreneurship. BAMF Health will occupy 45,000 sq ft for cancer treatment, with Ferris State University and Michigan Innovation Headquarters also involved. Construction begins next year.

Detroit’s Gratiot Site, once a failed criminal justice complex, will transform into a hub for innovation, health, and community development. Led by Bedrock, the 14-acre site will feature a Life Science Innovation Building, partnerships with educational institutions, and initiatives to address health disparities and create job opportunities. The project aims to honor Detroit’s history while fostering growth and inclusivity.

Bedrock announced a plan to transform the stalled Wayne County Criminal Justice Center site in Detroit into an innovation district focused on life sciences, technology, and entrepreneurship. The centerpiece will be a 220,000 sq ft Life Science Innovation Building with BAMF Health's research and outpatient facility. Partners include Michigan Innovation Headquarters, Ferris State University, Wayne State University, and TechTown Detroit. Construction is set to begin in 2025.

A cancer specialist praises a foundation's efforts to increase diversity in clinical trials through scholarships and internships. Patients respond more positively to doctors of similar backgrounds, but barriers like lack of knowledge, access, and biases affect participation. Diversity in trials is crucial for accurate results, and initiatives like community engagement and education are key to overcoming these challenges.

By 2030, 10.8 million Californians will be older adults, prompting focus on aging population. Black experts advocate for African American seniors' inclusion in research and clinical trials, highlighting underrepresentation and disparities in gerontology and Alzheimer's research. Efforts to improve diversity and trust in medical research are crucial for equitable healthcare.

After years of delays, FDA approves Phase 2 of MAPS' study on smoked medical marijuana for PTSD in veterans, funded by Michigan's cannabis tax revenue.

ESK981 + nivolumab showed no antitumor activity in AR+ mCRPC patients, with a maximum PSA decline of 14% and median rPFS of 3.7 months. The study was terminated due to futility.

Wayne State scientists develop AI models to reduce drug design costs, focusing on complex drug types. Stanford research shows ChatGPT-4 achieving 92% medical diagnostic accuracy, outperforming human doctors. Health tech stocks rose 12% in 2024, with AI healthcare companies attracting 38% of venture capital investments.